Cite
MLA Citation
A Yarur et al.. “DOP048 Vedolizumab levels during induction are associated with long-term clinical and endoscopic remission in patients with inflammatory bowel disease.” Journal of Crohn's and colitis, vol. 12, n.d., pp. S064–S065. http://access.bl.uk/ark:/81055/vdc_100095320852.0x00000f